SKYE BIOSCIENCE INC

Go to SKYE BIOSCIENCE INC Website

$3.63

0.00 (0.00%)
Live
Previous Close

$3.63

Day Range

$0 - $0

Previous Day Range

$3.4175 - $3.705

Market Cap

$105.7 million USD

Day Vol.

0

Previous Day Vol.

276792

Currency

USD

Primary Exchange

None

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Skye Bioscience will host a conference call on August 7, 2025 to discuss Q2 2025 financial results and provide a business update, focusing on their Phase 2 clinical trial for nimacimab in obesity treatment.

Related tickers: SKYE.

Read Full Article

Skye Bioscience, a clinical-stage biotechnology company, announced its participation in upcoming healthcare conferences and a partnership with Arecor Therapeutics to develop an enhanced formulation of its obesity candidate, nimacimab.

Related tickers: SKYE.

Read Full Article
Trending Tickers

Please sign in to view